Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare.
Cancer has impacted the lives of many of our friends and family. Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data. Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale. If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught. We see that by taking a quantitative approach, the data generated by our tools benefits preclinical research, clinical trials, and ultimately patients.
We are proud to partner with the following organizations
Latest research, in the news, or at events.
Research into developing effective treatments for non-alcoholic steatohepatitis (NASH) is becoming more important as the incidence of NASH increases in the general population. Mouse and rat models are used
The staggering cost of healthcare in America continues to rise, especially for wound healing. In 2014, wound-related healthcare expenses for Medicare beneficiaries were conservatively estimated at $28.1 billion, with
Precision medicine has come a long way towards benefiting patient outcomes and enhancing research tools. In recent years, the integration of multi-scale omics from genomic, proteomic, and transcriptomic foundations